TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
488
|
482
|
679 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-133
|
-182
|
5,195 |
| EBITDA |
-106
|
-154
|
355 |
| Total assets |
7,259
|
7,476
|
7,666 |
| Current assets |
115
|
350
|
543 |
| Current liabilities |
323
|
212
|
32 |
| Equity capital |
6,936
|
7,264
|
7,634 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
95.6%
|
97.2%
|
99.6% |
| Turnover per employee |
488
|
482
|
679 |
| Profit as a percentage of turnover |
-27.3%
|
-37.8%
|
765.1% |
| Return on assets (ROA) |
-1.8%
|
-2.4%
|
67.8% |
| Current ratio |
35.6%
|
165.1%
|
1696.9% |
| Return on equity (ROE) |
-1.9%
|
-2.5%
|
68.1% |
| Change turnover |
6
|
-197
|
-100 |
| Change turnover % |
1%
|
-29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.